GPN VACCINES
GPN Vaccines are a type of vaccine that is used to prevent the spread developing a vaccine against streptococcus pneumoniae.
GPN VACCINES
Industry:
Biotechnology
Founded:
2017-01-01
Address:
Adelaide, South Australia, Australia
Country:
Australia
Website Url:
http://www.gpnvaccines.com
Total Employee:
1+
Status:
Active
Contact:
08 8313 4671
Total Funding:
6.25 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
D2M Biotherapeutics
D2M Biotherapeutics focuses on the development of novel immunotherapeutics.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Current Employees Featured
Investors List
Forepont Capital Partners
Forepont Capital Partners investment in Series A - GPN Vaccines
Government of South Australia
Government of South Australia investment in Grant - GPN Vaccines
Government of South Australia
Government of South Australia investment in Grant - GPN Vaccines
National Health and Medical Research Council
National Health and Medical Research Council investment in Grant - GPN Vaccines
Official Site Inspections
http://www.gpnvaccines.com Semrush global rank: 5.93 M Semrush visits lastest month: 1.39 K
- Host name: 989347.cloudwaysapps.com
- IP address: 170.64.170.244
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "GPN Vaccines"
GPN Vaccines - Developing a Universal Pneumococcal …
Join us in pioneering the next generation of vaccines to prevent pneumococcal disease and in so doing contribute to advancing global health. Whether you have experience with clinical trials or are considering participating for the first time, …See details»
GPN Vaccines - Crunchbase Company Profile & Funding
GPN Vaccines is a clinical stage biotechnology company developing a Streptococcus pneumoniae vaccine. The company's vaccine is designed to prevent life-threatening …See details»
BioCina Expands Partnership with GPN Vaccines - PR …
Nov 6, 2023 ADELAIDE, South Australia, Nov. 6, 2023 /PRNewswire/ -- BioCina Pty Ltd., a global end-to-end biologics contract development and manufacturing organization (CDMO), announced the expansion of their ...See details»
GPN VACCINES LTD Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for GPN VACCINES LTD of YARRALUMLA, AUSTRALIAN CAPITAL TERRITORY. Get the latest …See details»
GPN Vaccines - LinkedIn
GPN Vaccines is a clinical-stage company focused on creating innovative vaccines that offer robust protection against the world's most important bacterial pathogens.See details»
GPN Vaccines Company Profile 2024: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for GPN Vaccines. Use the PitchBook Platform to explore the full profile.See details»
Human trials to begin on SA-made universal …
Nov 4, 2022 South Australian biotech company GPN Vaccines in collaboration with the University of Adelaide has developed a new, universal vaccine against the deadly bacterium Streptococcus pneumoniae.. A clinical trial to assess the …See details»
BioCina Expands Partnership With GPN Vaccines
Nov 6, 2023 <p>BioCina Pty Ltd., a global end-to-end biologics contract development and manufacturing organization (CDMO), announced the expansion of their partnership with GPN …See details»
Step forward for pneumonia vaccine development
Feb 4, 2019 Step forward for pneumonia vaccine development. Monday, 4 February 2019. A vaccine against the biggest bacterial killer on the planet is a step closer to being available with funding secured for preclinical trials.See details»
Small Business - The Interior Journal | The Interior Journal
Nov 6, 2023 BioCina is a global end-to-end biologics contract development and manufacturing organization (CDMO) of choice, offering process development and cGMP clinical & …See details»
BioCina Expands Partnership with GPN Vaccines - FOX40
Nov 6, 2023 ADELAIDE, South Australia, Nov. 6, 2023 /PRNewswire/ -- BioCina Pty Ltd., a global end-to-end biologics contract development and manufacturing organization (CDMO), …See details»
First Participant Dosed in Phase 1 Clinical Trial of Gamma-PN in …
GPN Vaccines Ltd is pleased to announce that the first participant has been dosed in its Phase 1 clinical trial of Gamma-PN vaccine in older adults. The Phase 1 clinical trial will assess the …See details»
GPN Vaccines Reports Positive Safety and Immunogenicity Data …
ADELAIDE, Australia, Jan. 3, 2024 /PRNewswire/ -- GPN Vaccines Ltd, a clinical-stage biotechnology company developing a Streptococcus pneumoniae vaccine to prevent life …See details»
"Whole bacterial" pneumonia vaccine approaches human trials
Feb 4, 2019 According to the World Health Organization (WHO), pneumonia is responsible for 16 percent of all deaths of children under five years of age, accounting for over 920,000 child …See details»
BioCina Expands Partnership with GPN Vaccines
Nov 6, 2023 BioCina Pty Ltd., a global end-to-end biologics contract development and manufacturing organization (CDMO), announced the expansion of their partnership with GPN …See details»
GPN Vaccines on LinkedIn: GPN Vaccines Reports Positive Safety …
Happy New Year to all our followers, supporters and partners! We are very pleased to start 2024 by announcing positive safety and immunogenicity data from our…See details»
GPN Vaccines’ Post - LinkedIn
Today marks an important milestone for GPN Vaccines; the first participant has been dosed in our first-in-human clinical trial of Gamma-PN. We would like to…See details»
How GPN Vaccines is outsmarting the pneumococcus - LinkedIn
Feb 14, 2023 GPN Vaccines was initially established with the goal of creating a vaccine capable of protecting children and adults against all serotypes of Streptococcus pneumoniae (the …See details»
Vaccines and immunization - Canada.ca
Government of Canada health information and facts about vaccination for children, adults, COVID-19, travel, during pregnancy, safety and side effects, information for health professionals.See details»
GPN Vaccines - Company Profile - Tracxn
3 days ago GPN Vaccines - Developer of a vaccine against Streptococcus pneumonia. Raised a total funding of $18M over 1 round from 4 investors. GPN Vaccines has 262 competitors.See details»